Novartis Hit With Gleevec Sham Litigation Class Action
Novartis Pharmaceuticals Corp. conspired to improperly withhold generic versions of Gleevec — a blockbuster leukemia medication — from the consumer market, two employee welfare funds alleged in a proposed class action...To view the full article, register now.
Already a subscriber? Click here to view full article